Ulrich O. Nagl
University of Innsbruck
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ulrich O. Nagl.
Pflügers Archiv: European Journal of Physiology | 1995
Martin Gschwentner; Ulrich O. Nagl; Ewald Wöll; Andreas Schmarda; Markus Ritter; M. Paulmichl
Cell volume regulation is an essential feature of most cells. After swelling in hypotonic media, the simultaneous activation of potassium and chloride channels is believed to be the initial, time-determining step in cell volume regulation. The activation of both pathways is functionally linked and enables the cells to lose ions and water, subsequently leading to cell shrinkage and readjustment of the initial volume. NIH 3T3 fibroblasts efficiently regulate their volume after swelling and bear chloride channels that are activated by decreasing extracellular osmolarity. The chloride current elicited in these cells after swelling is reminiscent of the current found in oocytes expressing an outwardly rectifying chloride current termed ICln. Introduction of antisense oligodeoxynucleotides complementary to the first 30 nucleotides of the coding region of the ICln channel into NIH 3T3 fibroblasts suppresses the activation of the swelling-induced chloride current. The experiments directly demonstrate an unambiguous link between a volume-activated chloride current and a cloned protein involved in chloride transport.
The Journal of Allergy and Clinical Immunology | 1996
Martin Gschwentner; Alex Susanna; Andreas Schmarda; Andreas Laich; Ulrich O. Nagl; Helmut Ellemunter; Peter Deetjen; Julian Frick; Markus Paulmichl
Cell volume regulation is a ubiquitous cell regulatory mechanism based on meticulously controlled ion transport mechanisms. Keeping the absolute volume constant seems to be of the highest priority for most cells and is achieved at the expense of altered intracellular ion concentrations. We have been able to demonstrate that ICln, a chloride channel cloned from epithelial cells, is paramount for the ability of swollen cells to regulate their volume back to that under resting conditions. A unique feature of ICln is the distinct sensitivity of these channels for nucleotides and nucleoside analogues added to the extracellular fluid. In addition, cromolyn sodium and nedocromil sodium, drugs used by patients with asthma, are able to impede the function of these channels.
Gene | 1998
Ulrich O. Nagl; Martin Erdel; Friederike Bergmann; Bernhard Oehl; Elke Scandella; Luciana Musante; Luis J. V. Galietta; Martin Gschwentner; Johannes Fürst; Andreas Schmarda; Sabine Hofer; Gerd Utermann; Peter Deetjen; M. Paulmichl
Expression cloning revealed a chloride channel (ICln) that we found to be fundamental for the regulatory volume decrease in a variety of cells. The chromosomal localization of the human ICln-gene showed two loci, one at chromosome 11 in position q13.5-q14.1, termed CLNS1A, and a second one at chromosome 6 at position p12.1-q13, termed CLNS1B. In this study, we offer a detailed characterization of the CLNS1A gene and provide the exact position (6p12) and sequence data of CLNS1B, an intronless gene 91.3% homologous to the coding region of CLNS1A.
Cellular Physiology and Biochemistry | 1997
Andreas Schmarda; Ulrich O. Nagl; Martin Gschwentner; Johannes Fürst; Sabine Hofer; Peter Deetjen; M. Paulmichl
Using expression cloning techniques, a protein was isolated which gave rise to an outwardly rectifying chloride current after expression in Xenopus laevis oocytes [Paulmichl et al., Nature 1992;356:238-241]. We termed this protein ICln and found it to be crucial for the regulatory volume decrease after swelling cells in hypotonic medium. Here we describe the cloning of the zebra fish homologue to ICln and, in addition, specify the epitope recognized by the antibodies we raised in rabbits against a synthetic peptide comprised by the C-terminal 24 amino acids of ICln·
Journal of Biological Chemistry | 2000
Elke Scandella; Ulrich O. Nagl; Bernhard Oehl; Fredericke Bergmann; Martin Gschwentner; Johannes Fürst; Andreas Schmarda; Markus Ritter; Siegfried Waldegger; Florian Lang; Peter Deetjen; M. Paulmichl
The ICln protein is expressed ubiquitously in mammals. Experiments designed to knock down the ICln protein in NIH 3T3 fibroblasts as well as in epithelial cells led to the conclusion that this protein is crucially involved in volume regulation after cytoplasmic swelling. Reconstitution of the ICln protein in lipid bilayers revealed the ion channel nature of ICln. Here we describe a new human promoter sequence, composed of 89 nucleotides, which is responsible for a highly constitutive expression of the ICln protein. The promoter sequence lacks a TATA box, and the transcription can be effected at multiple sites. In addition to the starting sites, upstream sequence elements are mandatory for an efficient transcription of the ICln gene (CLNS1A). These new nucleotide elements were defined by site-directed mutagenesis.
Molecular Medicine | 1995
Martin Gschwentner; Alex Susanna; Ewald Wöll; Markus Ritter; Ulrich O. Nagl; Andreas Schmarda; Andreas Laich; Germar M. Pinggera; Helmut Ellemunter; Huemer H
Kidney International | 1997
Andreas Laich; Martin Gschwentner; Wolfgang Krick; Ulrich O. Nagl; Johannes Fürst; Sabine Hofer; Alex Susanna; Andreas Schmarda; Peter Deetjen; Gerhard Burckhardt; M. Paulmichl
Genomics | 1996
Ulrich O. Nagl; Martin Erdel; Andreas Schmarda; Marco Seri; Germar M. Pinggera; Martin Gschwentner; Christoph Duba; Luis J. V. Galietta; Peter Deetjen; Gerd Utermann; M. Paulmichl
Genomics | 1998
Siegfried Waldegger; Martin Erdel; Ulrich O. Nagl; Petra Barth; Gertraud Raber; Silvia Steuer; Gerd Utermann; Markus Paulmichl; Florian Lang
Archive | 1996
Martin Gschwentner; Alex Susanna; Andreas Schmarda; Andreas Laich; Ulrich O. Nagl; Helmut Ellemunter; Peter Deetjen; Julian Frick